$345.6 K

Remedent Revenue Q2, 2019
Remedent Gross profit (Q2, 2019)229.1 K
Remedent Gross profit margin (Q2, 2019), %66.3%
Remedent EBIT (Q2, 2019)-112.6 K
Remedent Cash, 30-Sep-201855.1 K

Remedent Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

2.6m3.6m2.8m2.4m2.7m

Revenue growth, %

39%(23%)

Cost of goods sold

965.0k1.3m817.4k1.2m917.9k

Gross profit

1.6m2.3m2.0m1.2m1.8m

Gross profit Margin, %

63%65%70%50%66%

Sales and marketing expense

682.7k756.2k493.8k644.6k916.6k

R&D expense

77.5k61.2k8.8k8.4k1.9k

General and administrative expense

1.4m1.2m1.3m1.4m1.1m

Operating expense total

2.4m2.2m1.9m2.3m2.1m

Depreciation and amortization

240.0k254.8k158.5k154.8k100.3k

EBIT

(737.3k)105.4k7.2k(1.1m)(300.8k)

EBIT margin, %

(28%)3%0%(45%)(11%)

Interest expense

130.0k75.1k63.4k36.6k10.8k

Interest income

11.3k83.9k

Income tax expense

30.6k(22.9k)

Net Income

524.5k

Remedent Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

775.3k399.1k94.4k147.1k92.9k

Inventories

599.3k414.0k410.7k110.4k123.1k

Current Assets

3.4m2.9m2.9m1.3m1.7m

PP&E

489.4k435.3k410.9k274.4k143.7k

Total Assets

6.2m5.5m5.7m4.7m5.4m

Accounts Payable

598.6k846.8k789.3k1.0m1.6m

Current Liabilities

3.8m3.4m3.4m1.6m2.1m

Long-term debt

273.2k

Total Debt

273.2k

Total Liabilities

3.8m

Additional Paid-in Capital

24.9m24.9m24.9m24.9m24.9m

Retained Earnings

(21.1m)(21.0m)(20.8m)(20.0m)(20.0m)

Total Equity

2.3m2.1m2.3m3.2m3.3m

Financial Leverage

2.7 x2.6 x2.5 x1.5 x1.6 x

Remedent Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

524.5k

Depreciation and Amortization

240.0k254.8k158.5k154.8k100.3k

Accounts Receivable

160.4k(59.6k)(130.7k)34.6k(214.2k)

Inventories

392.6k185.2k3.3k300.3k(12.7k)

Accounts Payable

(385.8k)239.1k(48.5k)249.4k530.4k

Cash From Operating Activities

(103.9k)300.6k(203.1k)1.7m20.3k

Cash From Investing Activities

(81.4k)(240.5k)(116.3k)(37.6k)(4.5k)

Long-term Borrowings

(1.0m)

Cash From Financing Activities

1.2m(358.1k)(1.0m)

Interest Paid

63.0k25.1k13.4k11.5k10.8k

Remedent Ratios

USDY, 2018

Financial Leverage

1.7 x
Report incorrect company information